Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers

BMC Endocrine Disorders

Volumn 14, Issue 1, 2014, Pages

  Jung, Caroline ^a,b   Greco, Santo ^c   Nguyen, Hanh H T ^c   Ho, Jui T ^d   Lewis, John G ^e   Torpy, David J ^d,f,g   Inder, Warrick J ^h,i  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MELBOURNE PATHOLOGY   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e CANTERBURY HEALTH LABORATORIES   (New Zealand)

^f HANSON INSTITUTE   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adrenal Cortex; Cortisol; HPA axis (hypothalamic pituitary adrenal); Hydrocortisone

Indexed keywords

CREATININE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; TRANSCORTIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; MALE; MORNING DOSAGE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; SALIVA LEVEL; URINARY CORTISOL CREATININE RATIO;

EID: 84928692518     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-91     Document Type: Article

References (44)

1. Thomson AH, Devers MC, Wallace AM, Grant D, Campbell K, Freel M, Connell JM: Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clin Endocrinol (Oxf ) 2007, 66:789-796.
2. Besser GM, Jeffcoate WJ: Endocrine and metabolic diseases: Adrenal diseases. Br Med J 1976, 1:448-451.
3. Kenny FM, Preeyasombat C, Migeon CJ: Cortisol production rate II Normal infants, children, and adults. Pediatrics 1966, 37:34-42.
4. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL: Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991, 72:39-45.
5. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD: Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 1993, 76:1505-1510.
6. Kraan GP, Dullaart RP, Pratt JJ, Wolthers BG, Drayer NM, De Bruin R: The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998, 83:1247-1252.
7. Crown A, Lightman S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf ) 2005, 63:483-492.
8. Howlett TA: An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf ) 1997, 46:263-268.
9. Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM: ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 2009, 94:4216-4223.
10. Arlt W, Rosenthal C, Hahner S, Allolio B: Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf ) 2006, 64:384-389.
11. Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, Stettler C: Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 2012, 97:E1938-E1942.
12. Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ: Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf ) 2006, 65:45-50.
13. Lovas K, Husebye ES: Continuous subcutaneous hydrocortisone infusion in Addison's disease. Eur J Endocrinol 2007, 157:109-112.
14. Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT, Ross RJ: Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf ) 2008, 68:130-135.
15. Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W, Ross RJ: Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab 2009, 94:1548-1554.
16. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S: Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol 2009, 161:119-130.
17. Russell GM, Durant C, Ataya A, Papastathi C, Bhake R, Woltersdorf W, Lightman S: Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf ) 2014, 81:289-293.
18. Wong V, Yan T, Donald A, McLean M: Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clin Endocrinol (Oxf ) 2004, 61:131-137.
19. Ekman B, Fitts D, Marelli C, Murray RD, Quinkler M, Zelissen PM: European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy. BMC Endocr Disord 2014, 14:40.
20. Aanderud S, Myking OL: Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state. Acta Med Scand 1981, 210:157-161.
21. Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ: Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf ) 2004, 61:367-375.
22. Oelkers W: Adrenal insufficiency. N Engl J Med 1996, 335:1206-1212.
23. Kehlet H, Binder C, Blichert-Toft M: Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin Endocrinol (Oxf ) 1976, 5:37-41.
24. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ: Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf ) 1981, 14:451-458.
25. Coolens JL, Van Baelen H, Heyns W: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987, 26:197-202.
26. Maguire AM, Ambler GR, Moore B, Waite K, McLean M, Cowell CT: The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism. Eur J Endocrinol 2007, 156:471-476.
27. Lovas K, Thorsen TE, Husebye ES: Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. J Endocrinol Invest 2006, 29:727-731.
28. Burch WM: Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states. JAMA 1982, 247:2002-2004.
29. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP: Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf ) 1997, 46:255-261.
30. Jung C, Inder WJ: Management of adrenal insufficiency during the stress of medical illness and surgery. Med J Aust 2008, 188:409-413.
31. Debono M, Ross RJ, Newell-Price J: Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 2009, 160:719-729.
32. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008, 93:1526-1540.
33. Tunn S, Mollmann H, Barth J, Derendorf H, Krieg M: Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin Chem 1992, 38:1491-1494.
34. Aardal E, Holm AC: Cortisol in saliva-reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem 1995, 33:927-932.
35. Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, Stewart PM, Tomlinson JW, Lavery GG: 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 2014, 111:E2482-E2491.
36. Smans L, Lentjes E, Hermus A, Zelissen P: Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease. Hormones (Athens) 2013, 12:93-100.
37. Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, Lewis JG, Torpy DJ: Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006, 91:105-114.
38. Widmer IE, Puder JJ, Konig C, Pargger H, Zerkowski HR, Girard J, Muller B: Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005, 90:4579-4586.
39. Arafah BM: Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006, 91:3725-3745.
40. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B: Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997, 34:222-229.
41. Taylor AE, Karavitaki N, Foster M, Meier S, O'Neil DM, Komninos J, Vassiliadi DM, Mowatt CJ, Lord JM, Wass JAH, Arlt W: Prevention of adrenal crisis in stress: serum cortisol during elective surgery, acute trauma surgery and during "stress dose cover" hydrocortisone replacement in adrenal insufficiency. ENDO 2013 Poster abstract SAT-39.
42. Heazelwood VJ, Galligan JP, Cannell GR, Bochner F, Mortimer RH: Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. Br J Clin Pharmacol 1984, 17:55-59.
43. Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, Thompson CJ, Agha A: Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients. Clin Endocrinol (Oxf ) 2011, 75:505-513.
44. Barlow NL, Holme J, Stockley RA, Clark PM: An evaluation of measured and calculated serum free cortisol in a group of patients with known adrenal suppression. Ann Clin Biochem 2010, 47:200-204.